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Viridans group streptococci are major constituents of the normal human oral ﬂora and are also identiﬁed
as the predominant pathogenic bacteria in native valve infective endocarditis. Little information is available
regarding the regulation of gene expression in viridans group streptococci, either in response to changes in the
oral environment or during development of endocarditis. We therefore constructed a set of broad-host-range
vectors for the isolation of promoters from viridans group streptococci that are activated by speciﬁc environ-
mental stimuli in vitro or in vivo. A genomic library of Streptococcus gordonii strain CH1 was constructed in one
of the new vectors, and this library was introduced into a homologous bacterium by using an optimized
electroporation protocol for viridans group streptococci. Because viridans group streptococci entering the
bloodstream from the oral cavity encounter an increase in pH, we selected promoters upregulated by this
speciﬁc stimulus. One of the selected promoter sequences showed homology to the promoter region of the hydA
gene from Clostridium acetobutylicum, the expression of which is known to be regulated by the environmental
pH. The isolation of this pH-regulated promoter shows that S. gordonii can sense an increase in the environ-
mental pH, which serves as a signal for bacterial gene activation. Furthermore, this demonstrates the useful-
ness of these new selection vectors in research on adaptive gene expression of viridans group streptococci and
possibly also of other gram-positive bacteria.
Viridans group streptococci (VS) are major constituents of
the human commensal oral ﬂora (15). They constantly have to
adapt to the rapid changes in their natural habitat (4). Adap-
tation is characterized ﬁrstly by sensing of environmental
changes, followed by signal transduction, which can result in
the expression of genes whose products are involved in the
adaptive process (17, 30, 43). One of the environmental
changes VS encounter is variation in the extracellular pH,
which drops rapidly after carbohydrate consumption by the
host. Streptococcus mutans responds to such a decrease in pH
by rapid upregulation of the expression of several regulatory
genes and of genes involved in stress responses, including hcrA,
grpE, and dnaK (23). However, knowledge on gene expression
in other VS induced by pH or other environmental stimuli is
scarce.
VS, including Streptococcus sanguis, Streptococcus oralis, and
Streptococcus gordonii, are the most frequently encountered
bacterial causes of native valve infective endocarditis (IE) (10,
40). This disease is caused by the rapid growth and persistence
of bacteria embedded in a platelet-ﬁbrin thrombus (a vegeta-
tion) present on damaged endocardium or heart valves (12).
Studies on virulence factors of VS in the pathogenesis of IE
have mainly focused on components involved in bacterial ad-
herence to the vegetation. These include exopolysaccharides
(7, 31) and adhesins for connective-tissue proteins, for adhe-
sive macromolecules present in plasma, and for blood platelets
(3, 19, 25, 47). Little information is available on the regulation
of these and other possible virulence factors of VS in the host.
Therefore, we have developed a plasmid-based selection
system for the isolation of inducible VS promoters. The system
is designed partly in analogy to the in vivo expression technol-
ogy (IVET) system (18, 28), since IVET has been shown to be
a promising tool in the study of adaptive gene expression of VS
in an experimental rabbit model of IE [20; A. O. Kilic ¸, M. C.
Herzberg, X. Zhao, M. W. Meyer, and L. Tao, Abstr. ASM
Conf. Streptococcal Genet. (Genet. Streptococci, Enterococci,
Lactococci), abstr. LB-03, p. 41, 1998]. As VS experience an
increase in the environmental pH from slightly acidic to neu-
tral levels when entering the blood from the oral plaque (33),
we used this selection system to identify genes whose expres-
sion was inﬂuenced by this speciﬁc stimulus. A pH-regulated
promoter of S. gordonii strain CH1 was isolated and charac-
terized, showing that VS indeed recognize an increase in pH as
a signal for adaptive gene expression.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. Bacterial strains and plas-
mids used in this study are listed in Tables 1 and 2, respectively. Escherichia coli
strains BHB2600 and DH5a were cultured in Luria-Bertani broth and on Luria-
Bertani agar at 37°C. For maintenance of plasmids, ampicillin (50 mg/ml) or
erythromycin (150 mg/ml for strain BHB2600 and 300 mg/ml for strain DH5a)
was added to the growth medium. VS were cultured in Todd-Hewitt (TH) broth
and on TH agar (Difco Laboratories, Detroit, Mich.) at 37°C in a 5% CO2
atmosphere or anaerobically. When required, TH broth and TH agar were
supplemented with erythromycin (5 mg/ml).
MIC and MBC determination. The MICs and minimal bactericidal concen-
trations (MBCs) of spectinomycin for VS were determined by broth microdilu-
tion assays (32). Dilution series of spectinomycin or kanamycin, ranging from 25
to 1,000 mg/ml, in TH broth supplemented with 5% horse blood were prepared
in microtiter plates. To each well 100 ml of TH broth containing 10
6 bacteria was
added, and the plates were incubated overnight at 37°C in a 5% CO2 atmo-
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535sphere. The MIC was deﬁned as the lowest antibiotic concentration at which no
growth was visible. To determine the MBC, 1 ml from each well without visible
bacterial growth was cultured on blood agar plates. The MBC was deﬁned as the
lowest antibiotic concentration that reduced the bacterial inoculum at least
1,000-fold.
DNA isolation. Plasmid DNA was isolated from E. coli using Qiagen GmbH
(Hilden, Germany) plasmid DNA isolation kits and was isolated from VS as
described previously (52). Chromosomal DNA from VS was isolated using the
Puregene chromosomal DNA isolation kit for gram-positive bacteria and yeast
(Gentra Systems Inc., Minneapolis, Minn.).
Molecular cloning and DNA sequence determination. DNA manipulations
were done according to standard techniques (39). Plasmid DNA was introduced
into E. coli by electroporation using the method of Dower et al. (11). DNA
sequencing was performed with the PCR-mediated Taq Dye Deoxy Terminator
Cycle sequencing kit (Perkin-Elmer, Foster City, Calif.) using an Applied Bio-
systems model 373 DNA sequencer.
Construction of selection vectors pMM223 and pMM225. Plasmids used for
the construction of the selection vectors pMM223 and pMM225 are listed in
Table 2. The 3.3-kb BamHI-HindIII fragment of pEC2A (5), containing the
promoterless trp9-9lacZ fusion gene (9), was ligated to the EcoRI-BamHI part of
the pIC20R multiple cloning site (MCS) (29) and the product was introduced
into the EcoRI- and HindIII-digested shuttle vector pMG36e (49), resulting in
pMM201 (data not shown). To achieve higher cloning efﬁciencies, the MCS-trp9-
9lacZ fragment was excised from pMM201 as an EcoRI-KpnI fragment and
ligated to EcoRI- and KpnI-digested E. coli plasmid pLITMUS28 (14), creating
pMM210 (Fig. 1). Self-annealed primer AV7 (Table 3) was cloned into the KpnI
site of pMM210, replacing this site by an SpeI site (pMM211). The gene aad(9),
originating from Enterococcus faecalis and conferring resistance to spectinomycin
(27), was ampliﬁed as a promoterless gene from plasmid pORI19S (H. E. Smith,
personal communication) using primers AV3 and AV4 (Table 3). The 795-bp
PCR fragment was digested with BamHI and cloned into the BamHI site of
pMM211, resulting in pMM214. A bidirectional transcriptional terminator of
Streptococcus equisimilis H46A present on a 922-bp PstI-HindIII fragment of
plasmid pSU31 (45) was ampliﬁed using primers AV8 and AV9 (Table 2). The
terminator fragment was digested with SpeI and EcoRI and ligated in the re-
versed orientation in front of the selection cassette of pMM214 to generate
plasmid pMM218 (Fig. 1). For the construction of the second selection cassette,
the aphIII gene originating from E. faecalis plasmid pJH1 and conferring resis-
tance to kanamycin (48) was selected. It was ampliﬁed from plasmid pMG36 (49)
as a promoterless gene by using primers AV1 and AV2 (Table 3). The 855-bp
product was digested with BamHI and used to replace the BamHI fragment of
pMM218 comprising the promoterless aad(9) gene. The resulting plasmid was
designated pMM219. The selection cassettes were excised as SpeI fragments
from pMM218 and pMM219 and ligated to XbaI-digested pMM206, a derivative
of the lactococcal shuttle vector pGKV210 (50), to yield the vectors pMM223
[aad(9) Sp] and pMM225 (aphIII Km), respectively (Fig. 1).
Electrotransformation of VS. Electrocompetent VS cells were prepared ac-
cording to the method of Smith et al. (44), with minor modiﬁcations. Brieﬂy,
bacteria harvested from mid-log cultures in TH broth were washed three times
in ice-cold, sterile distilled water and three times in ice-cold 0.3 M sucrose–10%
glycerol. Bacteria were resuspended in 1/500 volume of the latter solution, and 50
ml of this suspension was used for electroporation with a Gene-Pulser and Pulse
Controller (Bio-Rad Laboratories B.V., Veenendaal, The Netherlands). Imme-
diately after electroporation, 0.95 ml of TH broth supplemented with 0.3 M
sucrose was added, and the bacteria were incubated for2ha t37°C and sub-
sequently plated on the appropriate selective agar medium. Colonies of VS
transformants were visible after 24 to 48 h of incubation at 37°C in a 5% CO2
atmosphere. To obtain maximal transformation frequencies, cuvettes with dif-
ferent electrode gap sizes (0.1 or 0.2 cm) were tested, and resistance setting (100
or 200 V), ﬁeld strength (10 to 25 kV/cm), and type of electrical pulse (decayed
pulse or squared pulse) were varied. In addition, the inﬂuence of procedures
affecting VS cell wall integrity on electroporation efﬁciencies was tested. DL-
Threonine (40 mM), 1% (vol/vol) glycine, or a sub-MIC concentration of peni-
cillin G was added to the growth medium used for the preparation of competent
VS cells, or competent VS were enzymatically treated with lysozyme (0.5 mg/ml;
Sigma Chemical Co., St. Louis, Mo.) and mutanolysin (2.5 U/ml; Sigma) for 1 h.
Natural transformation of S. gordonii CH1. S. gordonii CH1 cells were made
competent for natural transformation according to the method of Jenkinson
(24). Brieﬂy, an overnight culture in brain heart yeast (brain heart infusion
medium [Difco Laboratories] with5go fyeast extract [Difco] per liter) was
diluted 100-fold in fresh brain heart yeast supplemented with 5% horse serum
TABLE 1. Bacterial strains used in this study
Strain Source or reference
Escherichia coli DH5a..........................................Gibco-BRL (Breda,
The Netherlands)
Escherichia coli BHB2600....................................21
Streptococcus gordonii CH1..................................53
Streptococcus sanguis U108..................................8
Streptococcus sanguis S221...................................Our culture collection
Streptococcus sanguis S263...................................Our culture collection
Streptococcus bovis S225.......................................Our culture collection
Streptococcus bovis S228.......................................Our culture collection
Streptococcus oralis S195......................................Our culture collection
Streptococcus mutans S39.....................................Our culture collection
Streptococcus mutans V403..................................31
Streptococcus oralis J30.........................................8
Streptococcus oralis S223......................................Our culture collection
Streptococcus oralis S235......................................Our culture collection
Streptococcus oralis S245......................................Our culture collection
Streptococcus salivarius S304................................Our culture collection
Streptococcus salivarius S310................................Our culture collection
TABLE 2. Plasmids used in this study
Plasmid Relevant features Reference
pEC2A E. coli plasmid containing the trp9-9lacZ fusion gene; 7.5 kb; Em
r 5
pIC20R E. coli plasmid; 2.7 kb; Ap
r 29
pLITMUS28 E. coli plasmid; 2.8 kb; Ap
r 14
pMG36 Lactococcal expression vector; 3.7 kb; Km
r 49
pMG36e Lactococcal expression vector; 3.6 kb; Em
r 49
pGKV210 Lactococcal shuttle vector; 4.4 kb; Em
r 50
pORI19S Lactococcal shuttle vector; 3.9 kb; Sp
r Smith, personal
communication
pSU31 pUC19 containing the transcriptional terminator from S. equisimilis H46A; 6.2 kb; Ap
r 45
pMM201 pMG36e containing the EcoRI-BamHI part of pIC20R MCS and the trp9-9lacZ gene from pEC2A; 6.6 kb; Em
r This study
pMM206 Derivative of pGKV210 with a deletion of the EcoRI-BamHI fragment; 4.4 kb; Em
r This study
pMM210 pLITMUS28 containing the 3.4-kb EcoRI-KpnI fragment of pMM201; 6.2 kb; Ap
r This study
pMM211 pMM210 with self-annealed primer AV7 cloned into the KpnI site; 6.2 kb; Ap
r This study
pMM214 pMM211 with the promoterless aad(9) gene of pORI19S cloned into the BamHI site; 6.9kb; Ap
r This study
pMM218 pMM214 with the SpeI-EcoRI transcription terminator fragment from the pSU31; 7.0 kb; Ap
r This study
pMM219 pMM218 with the promoterless aphIII gene of pMG36 replacing the promoterless aad(9) gene; 7.1 kb; Ap
r This study
pMM223 pMM206 with the 4.3-kb SpeI fragment from pMM218 in the XbaI site; 8.1 kb; Em
r This study
pMM225 pMM206 with the 4.4-kb SpeI fragment from pMM219 in the XbaI site; 8.2 kb; Em
r This study
pMM239 pMM223 with the streptococcal rgg-gftG promoter fragment from S. gordonii CH1 in the EcoRI-SalI site;
9.2 kb; Em
This study
pMM240 pMM223 with the Sau3A fragment containing a constitutive promoter from S. gordonii CH1 in the BglII site;
9.0 kb; Em
r
This study
pMM243 pMM223 with the Sau3A fragment containing the neutral-pH-inducible promoter from S. gordonii CH1 in the
BglII site; 8.6 kb; Em
r
This study
536 VRIESEMA ET AL. APPL.E NVIRON.M ICROBIOL.FIG. 1. Schematic representation of the construction of selection vectors pMM223 and pMM225. Details of the construction are given in the text. TT, streptococcal
transcription terminator; Ap
R, ampicillin resistance gene; Em
R, erythromycin resistance gene; Cm, promoterless chloramphenicol acetyltransferase gene; B, BamHI;
Bg, BglII; C, ClaI; E, EcoRI; Ec, EcoRV; H, HindIII; K, KpnI; N, NruI; P, PstI; Sc, SacI; Sa, SalI; Sm, SmaI; S, SphI; Sp, SpeI; X, XbaI; Xh, XhoI. Endonucleases printed
in bold represent unique sites in the MCS.
VOL. 66, 2000 INDUCED PROMOTER ACTIVITY IN VS 537and 1% glucose and then incubated for3ha t37°C. This culture was diluted
100-fold in fresh medium and incubated for1ha t37°C. From this culture 1-ml
aliquots were taken, 1.5 mg of plasmid DNA was added, and incubation was
continued for another3ha t37°C. Aliquots of 10 ml were plated onto selective
TH agar and incubated for 24 to 48 h at 37°C in a 5% CO2 atmosphere to select
for plasmid-containing transformants.
b-Galactosidase activity assay. b-Galactosidase activities of the VS clones
were determined using the ﬂuorescent substrate ﬂuorescein di-b-galactopyrano-
side (FDG; Molecular Probes Europe BV, Leiden, The Netherlands). Bacteria
cultured overnight in TH broth containing erythromycin (5 mg/ml) were har-
vested by centrifugation, washed, and resuspended in STES buffer (10 mM
Tris-HCl, 100 mM NaCl, 1 mM EDTA, 20% sucrose) to an optical density at 620
nm (A620) of 1.0. Of this suspension 1.5 ml was centrifuged, the pellet was
resuspended in 1 ml of STES buffer supplemented with 50 mg of lysozyme per ml
and 200 U of mutanolysin per ml, and this suspension was incubated at 37°C.
After 2 h, 50 ml of 1% sodium dodecyl sulfate and 50 ml of chloroform were
added and the samples were mixed for 10 s and then were left standing for 15 min
at room temperature. Six replicate samples of 50 ml of this suspension were
transferred to wells of microtiter plates, 150 ml of Z buffer (40 mM NaH2PO4,6 0
mM Na2HPO4, 10 mM KCl, 1 mM MgSO4,4 0m Mb-mercaptoethanol [pH 7.0])
containing 33 mM FDG was added to each replicate, and microtiter plates were
incubated at 37°C. The emission was measured at different times at 530 nm
(band-pass wavelength 5 30 nm) after excitation at 485 nm (band-pass wave-
length 5 20 nm) using a Cytoﬂuor II ﬂuorescence multiwell plate reader (Per-
Septive Biosystems, Inc., Framingham, Mass.). The b-galactosidase activity was
plotted as arbitrary ﬂuorescence units over time, and results are the averages of
six reactions.
Construction of an S. gordonii CH1 genomic library. A genomic library of S.
gordonii CH1 was constructed using the selection vector pMM223. Vector DNA
was digested with BglII and dephosphorylated using calf intestine alkaline phos-
phatase (Boehringer Mannheim GmbH, Mannheim, Germany). Genomic DNA
isolated from S. gordonii CH1 was digested to completion with Sau3A. Vector
and chromosomal fragments were ligated, and the ligation mixture was intro-
duced into E. coli BHB2600 by electroporation. Plasmid DNA was isolated from
erythromycin-resistant transformants constituting the genomic library and intro-
duced into the homologous streptococcal strain CH1 by electroporation.
Selection of pH-regulated promoters. The streptococcal genomic bank was
plated onto TH agar of pH 7.3 supplemented with erythromycin (5 mg/ml) for
plasmid maintenance and spectinomycin (500 mg/ml) for selection of active
streptococcal promoters. After anaerobic incubation at 37°C for 36 h, colonies
resistant to erythromycin as well as spectinomycin were replated onto TH agar of
pH 6.2 supplemented with erythromycin and spectinomycin. As a control for the
viability of the isolated S. gordonii clones, these were also restreaked onto TH
agar plates of pH 6.2 supplemented with erythromycin only and onto plates of
pH 7.3 supplemented with erythromycin and spectinomycin. Plasmids were iso-
lated from clones that failed to grow on the pH 6.2 agar but that did grow on the
agar of pH 7.3 in the presence of spectinomycin. The fragments cloned in these
plasmids were ampliﬁed by PCR using primers AV4 and AV9 (Table 3), and the
PCR products were sequenced using primer AV19 (Table 3). The obtained
sequences were analyzed using the BLAST program (2).
Measurement of in vitro growth rate. To determine the relative activities of
promoters at different pH values, the growth rates of selected clones were
determined in TH broth of pH 6.2 and pH 7.3, in the presence and absence of
spectinomycin. A single colony of each clone was cultured at 37°C in TH broth
supplemented with erythromycin for plasmid maintenance. Overnight cultures
were diluted 100-fold in fresh TH broth containing both erythromycin (5 mg/ml)
and spectinomycin (500 mg/ml) or containing erythromycin alone. Growth was
monitored by measuring the A620 over time, and the mid-log-phase doubling time
(t1⁄2) was determined. Relative promoter activity at pH 6.2 and 7.3 was expressed
as the ratio of growth in the presence and absence of spectinomycin at each pH
[t1⁄2 (1spec)/t1⁄2(2spec)].
Statistical evaluation. The signiﬁcance of the differences between the growth
rate ratios at either pH was calculated with Student’s t test.
Nucleotide sequence accession numbers. The sequences of the vectors
pMM223 and pMM225 have been assigned GenBank accession numbers
AF076212 and AF076213, respectively. The sequence of the isolated pH-regu-
lated promoter fragment from S. gordonii CH1 pMM243 has been assigned
GenBank accession number AF127175.
RESULTS
New broad-host-range promoter selection vectors pMM223
and pMM225. We constructed a set of self-replicating broad-
host-range promoter selection vectors for gram-positive bac-
teria (Fig. 1). Firstly, selection cassettes were constructed in
E. coli plasmid pLITMUS28 (14). Each selection cassette
contains two promoterless genes. The ﬁrst gene is either a
promoterless aphIII gene (48), conferring resistance to kana-
mycin, or an aad(9) (27) gene, conferring resistance to specti-
nomycin, for the selection of active promoters. The second
gene is the trp9-9lacZ fusion gene, encoding b-galactosidase
(9), to be used for discrimination between constitutive and
induced promoter activities. In front of the two promoterless
genes, the MCS from pIC20R (29) was introduced for inser-
tion of DNA fragments with possible promoter activity. A bi-
directional transcriptional terminator from S. equisimilis strain
H46A (45) was cloned in front of the MCS to prevent possible
readthrough into the promoterless cassette. The terminator
was inserted in its reversed orientation, which has the highest
termination activity in E. coli TG1 (45). The resulting selection
cassettes have a total size of approximately 4.3 kb, and all
components of the cassettes can be replaced or removed sep-
arately or in combination, using common restriction endo-
nucleases (Fig. 1).
The cassettes were cloned as SpeI fragments into XbaI-di-
gested plasmid pMM206, a derivative of the lactococcal shuttle
vector pGKV210 (50), replacing the promoterless chloram-
phenicol acetyltransferase gene of pMM206. Plasmid pMM206
had been constructed by digestion of pGKV210 with EcoRI
and BamHI, ﬁlling in of the ends with Klenow large-fragment
DNA polymerase I, and ligation of the blunt ends. This vector
contains an erythromycin resistance gene for plasmid mainte-
nance and the broad-host-range origin of replication (ori)o f
plasmid pWV01 (26). The sequences of the new vectors were
assembled from published sequences of the different fragments
used and sequences obtained after sequence determination of
the borders of these fragments after ligation.
TABLE 3. Synthetic oligonucleotides used in this study
a
Primer Sequence (59-39) Restriction site
AV1 AACAGGATCCGGGGTATCTTTAAATACTGTAG BamHI
AV2 AACAGGATCCCGGGCTAGGTACTAAAACAATTCATCC BamHI/SmaI
AV3 AATTGGATCCCTAATCAAAATAGTGAGGAGG BamHI
AV4 AATTGGATCCCGGGTTTTTTTATAATTTTTTTAATCTG BamHI/SmaI
AV7 ATCATACTAGTATGATGTAC SpeI
AV8 AACAGAATTCACGGTCTTCTAAAACGATG EcoRI
AV9 ATGTCACTAGTCTCTACAAC SpeI
AV13 GATAAGATCTTGACGGAGATTAGCAAAAAG BglII
AV16 GATACTGCAGCCTTCTGAAAATAGTATAAAG PstI
AV19 CCTCCTCACTATTTTGATTAG
a Oligonucleotides were obtained from Perkin-Elmer Nederland B.V. (Nieuwerkerk aan de Ijssel, The Netherlands). Primers AV1-AV2, AV3-AV4, and AV8-AV9
were used to amplify the promoterless aad(9) gene, the promoterless aphIII gene, and the streptococcal transcriptional terminator, respectively. Oligonucleotide AV7
was self-annealed and used in the construction of the cassettes (Fig. 1). Underlined and bold sequences are recognition sites for the indicated endonucleases. AV9 and
AV19 were used for sequencing of the cloned chromosomal fragments.
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procedure using our standard S. sanguis test strain U108 and
shuttle vector pGKV210. Maximal efﬁciencies were obtained
using cuvettes with a 0.1-cm electrode gap at a resistance
setting of 100 V, a capacitance of 25 mF, and a ﬁeld strength of
25 kV/cm (Fig. 2). At these settings time constants ranged from
2.0 to 2.5 ms. The number of transformants increased linearly
with the plasmid DNA concentration over a range from 5 to
500 ng (data not shown). Despite the high ﬁeld strength, sur-
vival rates of S. sanguis U108 generally were 70% or higher.
Colonies of the U108 transformants were often variable in size,
but the introduced plasmid pGKV210 could be isolated from
the transformants in all cases.
Either culturing S. sanguis U108 in the presence of 1%
(vol/vol) glycine (22) or 40 mM DL-threonine (6) or treatment
of the bacteria with lysozyme (36, 42) and mutanolysin reduced
transformation frequencies at least ﬁvefold. Addition of a sub-
MIC concentration of penicillin G to the medium used to
prepare electrocompetent cells (35) or the use of a squared
instead of a decayed pulse (34) did not improve electropora-
tion.
To determine the transformability of other VS strains, sev-
eral laboratory strains and clinical endocarditis isolates were
electrotransformed with pGKV210. In these experiments, the
ﬁeld strength was reduced to 20 kV/cm, since at 25 kV/cm
arcing regularly occurred. S. gordonii CH1 and S. sanguis U108
had the highest transformation frequencies (2 3 10
4 and 7 3
10
3 CFU/mg of DNA, respectively), while for three other strains
(S. oralis J30, S. mutans S39, and S. sanguis S263) reasonable
numbers of transformants were obtained (4 3 10
3,13 10
3, and
4 3 10
2 CFU/mg of DNA, respectively). At 25 kV/cm, trans-
formation of S. gordonii CH1 was over 100-fold more efﬁcient
than that of S. sanguis U108 (Table 4).
Subsequently, electroporation efﬁciencies of pGKV210,
pMM223, and pMM225 were determined for both S. sanguis
U108 and S. gordonii CH1. The highest frequencies were ob-
tained with S. gordonii CH1 for all vectors tested (Table 4). As
this strain is known to be naturally transformable, efﬁciencies
of the optimized electroporation procedure and of natural
transformation were compared. The optimized electroporation
procedure proved to be superior, especially for the newly con-
structed vectors (Table 4).
Testing of expression vectors. To determine the spectino-
mycin level required for the selection of active promoters,
plasmid pMM239 was constructed. A 1.1-kb rgg-gtfG promoter
fragment (46) ampliﬁed from the genomic DNA of S. gordonii
CH1 using primers AV13 and AV16 was digested with BglII
and PstI and then cloned into the MCS of pMM223. The MICs
and MBCs for S. gordonii CH1 and S. sanguis U108 harboring
either plasmid pMM223 or pMM239 were assessed. The pres-
ence of the active gtfG promoter in pMM239 was well de-
tectable, since without plasmid or with pMM223 both strains
were susceptible to spectinomycin concentrations of ,25 mg/
ml, whereas S. gordonii CH1 and S. sanguis U108 harboring
pMM239 were resistant to .1,000 and .800 mg of spectino-
mycin per ml, respectively. The MICs of kanamycin for our test
strains, S. gordonii CH1 and S. sanguis U108 with or without
pMM225, were relatively high, 250 mg/ml, but the presence
of an active promoter in pMM225 increased the level of re-
sistance to .1,000 mg of kanamycin per ml. Thus, vectors
pMM223 and pMM225 allowed selection of active promot-
ers.
Subsequently, we evaluated the functionality of the promot-
erless lacZ reporter gene. In E. coli, promoter activity could
easily be detected by plating the organism on agar plates con-
taining 40 mg of 5-bromo-4-chloro-3-indolyl-b-D-galactoside
(X-Gal) per ml as a substrate. In S. gordonii CH1, the presence
of an active promoter could not be discriminated using either
agar plates or agar overlays containing up to 500 mg of X-Gal
per ml (1). All strains, carrying vectors with or without active
promoters, produced blue colonies after 2 to 3 days of incu-
bation. In liquid assays using FDG the presence of the rgg-gtfG
promoter on plasmid pMM239 could be detected in S. gordonii
CH1 after 20 h of incubation, despite the endogenous b-galac-
tosidase activity (Fig. 3). Although addition of 2% glucose to
the growth medium reduced this endogenous activity, it did not
improve the ability to detect an active promoter (data not
shown).
Selection of pH-regulated promoters of S. gordonii CH1. A
genomic library of S. gordonii CH1 was constructed in pMM223
by using E. coli as an intermediate host, since direct transfor-
mation of ligation mixtures to S. gordonii CH1 resulted in low
numbers of recombinant clones. We used pMM223 because
FIG. 2. Electroporation frequency of S. sanguis strain U108 as function of
ﬁeld strength. The lactococcal shuttle vector pGKV210 was used as the donor
DNA. Electroporation cuvettes with an electrode gap of 0.1 cm were used at a
resistance setting of 100 V (squares) or 200 V (triangles) and a capacitance
of 25 mF.
TABLE 4. Efﬁciencies of transformation of pGKV210 and derived
vectors into S. sanguis U108 and S. gordonii CH1
Vector Frequency in S. sanguis
U108 of electroporation
Frequency in S. gordonii CH1 of:
Electroporation Natural transformation
pGKV210 4 3 10
4 5 3 10
6 2 3 10
5
pMM223 ,10
2 7 3 10
3 3 3 10
2
pMM225 ,10
2 5 3 10
3 ,10
2
VOL. 66, 2000 INDUCED PROMOTER ACTIVITY IN VS 539the background resistance of S. gordonii CH1 to spectinomycin
was very low (see above). The ﬁnal streptococcal genomic
library contained approximately 10
5 independent clones, with
an average insert size of approximately 500 bp. Statistically, this
library represents the entire genome of S. gordonii CH1 (39).
VS causing IE translocate from the oral plaque to the blood,
and the bacteria are exposed to a pH shift from pH 6.0 to 6.5
(33) to pH 7.3 to 7.4. Therefore, we selected promoters which
were upregulated at pH 7.3. Of 143 individual clones that grew
on TH agar of pH 7.3 supplemented with 500 mg of spectino-
mycin per ml, 5 clones were identiﬁed which hardly grew on
TH agar of pH 6.2 when spectinomycin was present. The pH of
the medium inﬂuenced the activity of b-galactosidase (data not
shown), hampering assessment of relative promoter activity.
Therefore, the promoter activities of one of these clones
[CH1(pMM243] at pH 6.2 and 7.3 were further tested by de-
termination of the in vitro growth rate in the presence or
absence of spectinomycin. The growth rate was signiﬁcantly
higher at pH 7.3 than at pH 6.2 (0.94 6 0.01 and 0.69 6 0.04,
respectively [P 5 0.0005] as compared to a clone [CH1
(pMM240)] that harbors a constitutive streptococcal promoter
(0.98 6 0.01 and 0.95 6 0.01 at pH 7.3 and pH 6.2, respec-
tively), demonstrating the upregulation of the pH-regulated
promoter at pH 7.3.
Sequencing of the pH-regulated promoter fragment and
comparison to GenBank sequences revealed homology to the
promoter region of the hydA gene of Clostridium acetobutyli-
cum (Fig. 4). The 235 and 210 regions were identiﬁed at al-
most identical positions in the two sequences. The extended
210 sequence present in the clostridial hydA promoter region
(59-AatATga-39) (lowercase letters represent nucleotides that
were not conserved in the extended 210 region)(54) was found
at the same position upstream of the 210 box of the strepto-
coccal promoter. The inverted repeat sequences present up-
stream and downstream of the Clostridium promoter stretch,
involved in catabolite repression (13, 16) and repression of the
transcription of hydA (16, 51), respectively, were, however, not
identiﬁed in the streptococcal sequence. A possible Shine-
Dalgarno sequence and translation start were found (Fig. 4).
The cloned fragment contained only the sequence encoding
the ﬁrst 24 amino acids of the putative coding region following
this translation start. This sequence did not show homology to
any entry in the GenBank database or to the partly sequenced
genomes of S. mutans, Streptococcus pneumoniae, and Strepto-
coccus pyogenes.
DISCUSSION
Apart from being important colonizers of the oral cavity and
upper pharyngeal tract in humans, VS are recognized as the
most common bacterial agents causing native valve IE (10, 40).
Little information is available regarding the adaptive potential
of this group of microorganisms, either in their natural habitat
or during the pathogenesis of IE. Of techniques to study adap-
tive gene expression (38), the IVET system is most suited for
selection of promoters of genes induced under speciﬁc in vitro
conditions or in the complex in vivo environment (28). In its
original design, the IVET system used integration of a non-
replicative vector into genomic DNA via a single crossover.
This approach requires high frequencies of transformation,
which are difﬁcult to achieve in many gram-positive bacteria. In
addition, although the IVET system was originally developed
to not disrupt any bacterial genes (28), integration of a non-
replicative vector containing a fragment without a promoter
may still cause mutations. We therefore developed an IVET-
based selection-reporter system using self-replicating plasmids
to study inducible genes in VS. Promoterless genes conferring
resistance to kanamycin (aphIII) and spectinomycin [aad(9)]
were chosen for the selection of active promoters, as these
antibiotics are bactericidal for our VS (data not shown). The
use of bacteriostatic antibiotics and associated resistance genes
[20; Kilic ¸ et al., Abstr. ASM Conf. Streptococcal Genet. (Gen-
et. Streptococci, Enterococci, Lactococci)] may result in erro-
neous selection of surviving bacteria that do not have a cloned
active promoter. Plasmids pMM223 and pMM225 carry the
replication origin (ori) of the lactococcal plasmid pWV01
(three to ﬁve copies per cell in lactococci, streptococci, and
Bacillus subtilis) (26). Because of their low copy number, these
selection vectors are expected not to interfere signiﬁcantly with
regulation of gene expression in these gram-positive bacteria.
VS generally are refractory to electrotransformation. Weak-
ening of cell walls by various methods, which increased trans-
formation frequencies for several gram-positive bacteria (6, 22,
35, 36, 42), did not improve the transformation frequencies of
our VS strains. With the optimized electroporation protocol,
transformation frequencies appeared to increase almost lin-
early with increasing ﬁeld strength and were maximal at 25
kV/cm (Fig. 2). At this maximum attainable ﬁeld strength, only
approximately 30% of the competent VS were killed. For E.
coli, maximal transformation frequencies are obtained when 50
to 75% of the cells are killed due to the electrical discharge
(11). Thus, even higher transformation frequencies might be
FIG. 3. Assessment of b-galactosidase activity in S. gordonii CH1 harboring
either plasmid pMM223 (no promoter [hatched bars]) or pMM239 (active rgg-
gtfG promoter [dotted bars]) using the ﬂuorescent substrate FDG.
540 VRIESEMA ET AL. APPL.E NVIRON.M ICROBIOL.possible with equipment capable of generating higher ﬁeld
strengths. S. gordonii CH1 and S. sanguis U108 had the highest
transformation frequencies of the 15 strains tested. Plasmid
size and possibly the plasmid-borne genes appeared to inﬂu-
ence transformation efﬁciencies, as pMM223 and pMM225
had lower frequencies than pGKV210 in both S. sanguis U108
and S. gordonii CH1. Electroporation was superior to natural
transformation of S. gordonii CH1 (Table 4), and frequencies
were sufﬁciently high to construct a representative genomic
bank.
Active promoters of S. gordonii CH1 could be detected using
the promoterless spectinomycin resistance gene of pMM223
and the kanamycin resistance gene of pMM225. Detection of
the induced expression of the promoterless trp9-9lacZ in these
plasmids proved to be more difﬁcult in our test strains, al-
though this reporter gene has successfully been used in the
closely related S. pneumoniae (5). S. gordonii CH1 harboring
pMM239, which carries the active rgg-gtfG promoter fragment
(46), could not be discriminated from S. gordonii CH1 carrying
pMM223 without a promoter, either on X-Gal-containing
plates or in agar overlays (1). Using the ﬂuorescent substrate
FDG, elevated b-galactosidase levels in lysates of bacterial
clones harboring pMM239 could be recorded after 20 h of in-
cubation (Fig. 3). Although the b-galactosidase expression of
S. gordonii CH1 was subject to catabolite repression, as dem-
onstrated by reduction of expression in the presence of 2%
glucose, glucose did not improve discrimination between the
presence and absence of an active promoter. The use of a
streptococcal mutant with lower endogenous b-galactosidase
activity, as described for S. pneumoniae (1), could be a suitable
alternative. Secondly, the E. coli lacZ gene might be replaced by
the recently described b-galactosidase gene of Bacillus stearo-
thermophilus [Poyart and Trieu-Cuot, Abstr. ASM Conf. Strep-
tococcal Genet. (Genet. Streptococci, Enterococci, Lactococci)].
From an S. gordonii CH1 genomic library constructed in
vector pMM223 a promoter fragment was isolated whose ac-
tivity was upregulated by a shift from oral plaque pH (6.2) to
blood pH (7.3). Part of this fragment showed homology to the
promoter region of the hydA gene of C. acetobutylicum ATCC
824 (16), which encodes a putative hydrogenase with strong
homology to the [Fe] hydrogenases from Desulfovibrio and
other Clostridium species. The expression of C. acetobutylicum
hydA is downregulated at the transcriptional level by a de-
crease in environmental pH (16). A more detailed study on the
putative streptococcal promoter would be required to conﬁrm
its localization on the isolated fragment and determine the
mode of transcription regulation. However, the activity of the
promoter on the isolated fragment was clearly regulated by the
environmental pH, showing that our selection method allows
isolation of promoters responding to environmental changes.
In their study using an IVET chromosomal integration sys-
tem, Kilic ¸ and coworkers selected 13 inducible promoters from
S. gordonii V288 in a rabbit model of IE. The genes controlled
by the isolated promoters encode proteins involved in different
cellular functions, including rapid bacterial growth and resis-
tance to host defense [20; Kilic ¸ et al., Abstr. ASM Conf. Strepto-
coccal Genet. (Genet. Streptococci, Enterococci, Lactococci)].
A hydA promoter homolog as identiﬁed in our study was not
among these selected promoters. The environmental stimuli
responsible for induction of the identiﬁed inducible genes are
still unknown.
To gain a more complete understanding of the regulation
of expression of in vivo-induced genes, and of other virulence
genes, it is crucial to identify the stimuli responsible for their
induction. To our knowledge this report is the ﬁrst one on the
isolation of a VS promoter sequence whose activity is directly
inﬂuenced by a shift from oral to blood pH. Such a stimulus
might also be an important signal for gene induction in other
bacterial species. We are presently studying whether the ex-
pression of more VS genes is inﬂuenced in response to this pH
change and whether this response involves a common regula-
tory mechanism. These insights will possibly also contribute to
a better understanding of the pathogenesis of IE.
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